Aspen Investment Management Inc Amgen Inc Transaction History

Aspen Investment Management Inc

$215 Million
Q4 2024

A detailed history of Aspen Investment Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Aspen Investment Management Inc holds 5,541 shares of AMGN stock, worth $1.61 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

5,541

Previous 5,556 0.27%

Holding current value

$1.61 Million

Previous $1.79 Million 19.33%

% of portfolio

0.67%

Previous 0.83%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	SELL	$258.78 - $328.31 $3,881 - $4,924	-15 Reduced 0.27%	5,541 $1.44 Million
Q3 2024 Nov 08, 2024	BUY	$309.38 - $337.38 $5,878 - $6,410	19 Added 0.34%	5,556 $1.79 Million
Q2 2024 Jul 26, 2024	SELL	$262.75 - $319.31 $6,306 - $7,663	-24 Reduced 0.43%	5,537 $1.73 Million
Q1 2024 Apr 26, 2024	SELL	$268.87 - $324.56 $9,141 - $11,035	-34 Reduced 0.61%	5,561 $1.58 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $3,835 - $4,326	-15 Reduced 0.27%	5,595 $1.61 Million
Q3 2023 Nov 01, 2023	SELL	$218.65 - $271.46 $26,675 - $33,118	-122 Reduced 2.13%	5,610 $1.51 Million
Q2 2023 Jul 28, 2023	SELL	$214.27 - $253.37 $23,998 - $28,377	-112 Reduced 1.92%	5,732 $1.27 Million
Q1 2023 May 16, 2023	SELL	$225.79 - $275.2 $14,676 - $17,888	-65 Reduced 1.1%	5,844 $1.41 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $68,250 - $86,720	-298 Reduced 4.8%	5,909 $1.55 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $5,835 - $6,581	26 Added 0.42%	6,207 $1.4 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $3,460 - $3,851	-15 Reduced 0.24%	6,181 $1.5 Million
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $19,295 - $21,346	-88 Reduced 1.4%	6,196 $1.5 Million
Q4 2021 Jan 26, 2022	SELL	$198.88 - $227.6 $175,014 - $200,288	-880 Reduced 12.28%	6,284 $1.41 Million
Q3 2021 Dec 06, 2021	SELL	$212.27 - $248.7 $88,516 - $103,707	-417 Reduced 5.5%	7,164 $1.52 Million
Q2 2021 Aug 04, 2021	BUY	$233.58 - $259.14 $28,029 - $31,096	120 Added 1.61%	7,581 $1.85 Million
Q1 2021 Jun 10, 2021	SELL	$221.91 - $258.6 $1,109 - $1,293	-5 Reduced 0.07%	7,461 $1.86 Million
Q4 2020 Jan 25, 2021	BUY	$216.38 - $257.67 $12,982 - $15,460	60 Added 0.81%	7,466 $1.72 Million
Q3 2020 Nov 30, 2020	BUY	$234.65 - $260.95 $31,208 - $34,706	133 Added 1.83%	7,406 $1.88 Million
Q2 2020 Aug 06, 2020	BUY	$197.81 - $242.74 $117,301 - $143,944	593 Added 8.88%	7,273 $1.72 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $71,984 - $95,471	-395 Reduced 5.58%	6,680 $1.35 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $10,406 - $13,376	55 Added 0.78%	7,075 $1.71 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $27,857 - $33,379	-160 Reduced 2.23%	7,020 $1.36 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $12,970 - $14,622	70 Added 0.98%	7,180 $1.49 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $7,472 - $8,392	-45 Reduced 0.63%	7,110 $1.31 Million
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $1.2 Million - $1.37 Million	7,155	7,155 $1.33 Million

Others Institutions Holding AMGN

# of Institutions

3,144

Shares Held

415M

Call Options Held

8.2M

Put Options Held

6.65M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspen Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Aspen Investment Management Inc with notifications on news.

Account

Aspen Investment Management Inc Amgen Inc Transaction History